
Loading, please wait...

Loading, please wait...

A recent longitudinal study published in Cardiovascular Diabetology highlights a significant link between the glucose disposal rate stroke risk and long-term metabolic health. Researchers examined how cumulative exposure to the estimated glucose disposal rate (eGDR) affects the incidence of stroke across various stages of cardiovascular-kidney-metabolic (CKM) syndrome. Given the rising prevalence of metabolic disorders in India, understanding these biomarkers is essential for preventive care.
The estimated glucose disposal rate (eGDR) serves as a reliable marker for peripheral insulin sensitivity. Specifically, clinicians calculate it using waist circumference, hypertension status, and HbA1c levels. In this study involving over 5,000 participants, scientists tracked eGDR levels over several years. Notably, they found that individuals with higher cumulative eGDR values enjoyed a much lower risk of developing a stroke. Consequently, maintaining high insulin sensitivity appears protective against cerebrovascular events. Moreover, the relationship remains consistent across all stages of CKM syndrome.
The research identified four distinct patterns of eGDR changes over time. Compared to those with persistently low eGDR, participants in the stable high group saw a 71% reduction in stroke risk. Furthermore, every 1-unit increase in cumulative eGDR was associated with a 5% reduction in stroke odds. These results confirm a linear inverse relationship. Therefore, monitoring long-term insulin sensitivity could provide better risk stratification for patients. Additionally, even those with a rapid decrease in eGDR showed lower risk than the persistent low group, suggesting that any period of higher sensitivity is beneficial.
Managing CKM syndrome requires a multi-faceted approach. Because eGDR is easy to calculate in clinical settings, it may serve as a valuable tool for identifying high-risk patients. Clinicians should focus on improving insulin sensitivity through lifestyle modifications and targeted therapies. By doing so, they may significantly reduce the long-term burden of stroke in metabolic patients. Similarly, routine monitoring of HbA1c and waist circumference can help track these changes effectively.
eGDR is a marker of insulin sensitivity. Higher levels indicate better metabolic health, which is directly linked to a lower risk of stroke in patients with cardiovascular-kidney-metabolic syndrome.
Researchers calculate eGDR using a specific formula involving waist circumference, the presence of hypertension, and HbA1c percentages to assess long-term metabolic exposure and cardiovascular risk.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A 6-year study finds that higher cumulative glucose disposal rate (eGDR) is linked to a significantly lower risk of incident stroke in CKM syndrome patients...
6 months ago

Recent research reveals that multiple system atrophy subtypes share an identical α-synuclein strain conformation, indicating that clinical heterogeneity stems from the initial anatomical site of onset rather than distinct structural strains.
Today

A retrospective cohort study reveals that simulation-free vaginal cuff brachytherapy achieves low 5-year vaginal recurrence rates comparable to simulation-verified protocols in high-intermediate risk endometrial cancer, supporting streamlined radiation oncology workflows.
Today

A systematic review evaluates machine learning models predicting cardiovascular adverse events in cancer patients, highlighting XGBoost performance, calibration gaps, and validation needs.
Today

A breakthrough study reveals how the agricultural fungicide thiram disrupts hepatic and tibial calcium homeostasis through ER stress and IP3R1/VDAC1 hyperactivation, uncovering a critical liver-bone axis of systemic toxicity.
Today

A new study in JMIR AI validates a unified multistage framework to detect and mitigate AI bias in healthcare, revealing critical trade-offs between demographic fairness, calibration, and discrimination.
Today